Phagenesis
UK - ManchesterMedical Devices
Focus: Phagenesis is a UK-based medical device company specializing in neurostimulation technology for swallowing control (dysphagia), primarily focused on post-stroke recovery applications. The company operates as a public entity with a focused product portfolio centered on the Phagenyx® System.
Profile data last refreshed 20h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Phagenesis
AI assessmentNot HiringNo open roles listed right now. Follow Phagenesis to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Phagenyx® System
Stable
Growth
Flagship neurostimulation device for dysphagia management with active clinical trial support across multiple indications.
Pipeline & Clinical Trials
Help build intelligence for Phagenesis
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.